ArticleJournal of clinical research in pediatric endocrinology2026
Type 1 Diabetes Mellitus and Transfer from Pediatric to Adult Care: A Single-Center Experience
Article in Journal of clinical research in pediatric endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Type 1 diabetes mellitus (T1DM) requires lifelong follow-up, and the transition from pediatric to adult care may influence clinical outcomes. To evaluate sociodemographic, clinical, and laboratory characteristics associated with the transition process in patients with T1DM and to compare two different transition models. Methods: Patients with T1DM transferred to an adult outpatient clinic between 2001 and 2022 were retrospectively assessed. Demographic data, metabolic parameters, complications, and treatment modalities before and after transition were assessed. Transition was performed either as a single-session model (Model 1) or as a gradual process over 4-6 months (Model 2). Results: A total of 64 patients transitioned over the 21 year study period. The annual number of follow-up visits was significantly lower in adult care (3.0±0.9 vs. 2.1±1.8 visits/year; p=0.009). HbA1c levels were also lower in adulthood (8.9% vs. 8.3%; p=0.007). Total insulin dose was lower (0.95 vs. 0.75 IU/kg/day; p=0.009), whereas the basal insulin ratio was higher (43.1% vs. 52.8%; p<0.0001). Although mean body mass index slightly decreased, obesity prevalence increased. No significant differences were observed between the two transition models in terms of glycemic outcomes, insulin requirements, or complication rates. Conclusion: A structured transition process was associated with improved glycemic control and treatment adaptation in T1DM, regardless of whether it is implemented as a single-session or gradual model. The absence of major differences between models may support the importance of individualized, patient-centered transition strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.